The study aimed to analyze PET/CT findings and dose distribution in patients with T1/T2N0M0 glottic cancer undergoing radiotherapy.
Researchers examined data from 29 patients, noting significant differences in tumor characteristics such as maximum standardized uptake value (SUVmax) and total lesion glycolysis (TLG) between T1 and T2 tumors, with implications for treatment planning.
The study concluded that PET/CT can effectively differentiate between T1 and T2 cancers, which correlates with variations in radiation dose required for effective treatment.